Internal Server Error

NanoScoping - About the company

NanoScoping is an unfunded company based in Palhoca (Brazil), founded in 2014 by Leticia Mazzarino, Manuel Adalberto Alfaro De Pra and maria beatriz veleirinho. It operates as a Developer of nano-capsules for the veterinary sector. NanoScoping has not raised any funding yet. The company has 471 active competitors, including 129 funded and 53 that have exited. Its top competitors include companies like Ceva, Zoetis and Liquidia.

Company Details

Social
Facebook
Email ID
*****@nanoscoping.com.br
Phone Number
+55 **********
Key Metrics
Founded Year
2014
Location
Palhoca, Brazil
Stage
Unfunded
Ranked
Employee Count
25 as on Apr 30, 2026
Similar Companies
Sign up to download NanoScoping's company profile

NanoScoping's funding and investors

NanoScoping has not raised any funding rounds yet.

NanoScoping's founders and board of directors

Founder? Claim Profile
Here are the details of NanoScoping's key team members:

NanoScoping's employee count trend

NanoScoping has 25 employees as of Apr 26. Here is NanoScoping's employee count trend over the years:
Employee count trend for NanoScoping
lockUncover NanoScoping's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

NanoScoping's Competitors and alternates

Top competitors of NanoScoping include Ceva, Zoetis and Liquidia. Here is the list of Top 10 competitors of NanoScoping, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Ceva
Ceva
1999, Libourne (France), Acquired
Global animal health company providing innovative solutions for diverse animal species
$214M
74/100
2nd
Logo for Zoetis
Zoetis
2013, Parsippany (United States), Public
Global animal health company dedicated to nurturing the world through animal care
-
72/100
3rd
Logo for Liquidia
Liquidia
2004, Morrisville (United States), Public
Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions
$90.3M
68/100
4th
Logo for Acorda
Acorda
1995, Ardsley (United States), Acquired
Developer of therapies that restore neurological function
$66.5M
66/100
5th
Logo for Genedit
Genedit
2016, Berkeley (United States), Series B
Developer of drug delivery system for genetic medicines
$93.5M
65/100
6th
Logo for Sirnaomics
Sirnaomics
2007, Gaithersburg (United States), Public
Developer of RNA based therapeutics for the treatment of cancer and fibrosis disease
$267M
63/100
7th
Logo for Aera
Aera
2021, Boston (United States), Series B
Developer of genetic medicines across a wide range of therapeutic areas
$193M
62/100
8th
Logo for NanoSyrinx
NanoSyrinx
2018, Coventry (United Kingdom), Series A
Developer of targeted intracellular delivery platform for biological molecules
$21.6M
61/100
9th
Logo for Avadel Pharmaceuticals
Avadel Pharmaceuticals
1990, Dublin (Ireland), Acquired
Pharma company with proprietary drug delivery tools and drug for narcolepsy
-
59/100
10th
Logo for Helex
Helex
2021, New York City (United States), Seed
Provider of next-generation gene-editing therapies
$6M
59/100
215th
Logo for NanoScoping
NanoScoping
2014, Palhoca (Brazil), Unfunded
Developer of nano-capsules for the veterinary sector
-
-
28/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on NanoScoping's competitors? Click here to see the top ones

NanoScoping's Investments and acquisitions

NanoScoping has made no investments or acquisitions yet.

FAQs about NanoScoping

Explore our recently published companies
  • Pure Asset - United Kingdom based, Unfunded company
  • Sekisan - Unfunded company
  • Aseltd - Parma based, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford